Recipharm signs partnership agreement on pharmaceutical development with Follicum
Tuesday, June 02, 2015
Recipharm signs partnership agreement on pharmaceutical development with Follicum.
Agreement concerns preparation for a clinical trial of drug candidate FOL-005.
Says product is expected to be ready at end of year, in time for launch of clinical study.
Has been engaged to formulate and produce product that will be used in clinical trial.
uk.reuters.com
